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The Maintenance of Lymphatic Vessels in the Cornea Is
Dependent on the Presence of Macrophages
Kazuichi Maruyama,1–3 Toru Nakazawa,4 Claus Cursiefen,5 Yuko Maruyama,1
Nico Van Rooijen,3 Patricia A. D’Amore,2 and Shigeru Kinoshita2
PURPOSE. It has been shown previously that the presence in the
cornea of antigen-presenting cells (APC), such as macrophages
(MPS) and lymphangiogenesis, is a risk for corneal transplan-
tation. We sought to determine whether the existence of
lymphatic vessels in the non-inflamed cornea is associated with
the presence of MPS.
METHODS. Flat mounts were prepared from corneas of
untreated C57BL/6, CD11b-/-, F4/80-/-, and BALB/c mice,
and after suture placement or corneal transplantation, ob-
served by immunofluorescence for the presence of lymphatic
vessels using LYVE-1 as a marker of lymphatic endothelium.
Innate immune cells were detected in normal mouse corneas
using CD11b, F4/80, CD40, as well as MHC-class II. Digital
images of the flat mounts were taken using a spot image
analysis system, and the area covered by lymphatic vessels was
measured using NIH Image software.
RESULTS. The number of spontaneous lymphatic vessels in
C57BL/6 corneas was significantly greater than in BALB/c
corneas (P ¼ 0.03). There were more CD11bþ (P < 0.01) and
CD40þ, MHC-class II (þ) cells in the C57BL/6 corneas than in
BALB/c mouse corneas. MPS depletion via clodronate liposome
in C57BL/6 mice led to fewer spontaneous lymphatic vessels
and reduced inflammation-induced lymphangiogenesis relative
to control mice. Mice deficient in CD11b or F4/80 had fewer
spontaneous lymphatic vessels and less lymphangiogenesis
than control C57BL/6 mice.
CONCLUSIONS. C57BL/6 mouse corneas have more endogenous
CD11bþ cells and lymphatic vessels. The endogenous lymphat-
ic vessels, along with pro-inflammatory MPS, account for the
high risk of corneal graft rejection in C57BL/6 mice. CD11bþ
and F4/80þ MPS appear to have an important role in of the
formation of new lymphatic vessels. (Invest Ophthalmol Vis
Sci. 2012;53:3145–3153) DOI:10.1167/iovs.11-8010
Blood and lymphatic vessels are critical to organ and tissuemaintenance. In particular, the lymphatic system is central
to the tissue fluid homeostasis, and to the return of
macromolecules and immune cells to the blood stream.
However, some tissues, including the cornea, have neither
vascular nor lymphatic vessels. The lack of a vascular supply is
essential to maintaining the transparency of the cornea. The
cornea obtains its nutrients by diffusion from the aqueous fluid
and the tears. The mechanisms that underlie the avascularity of
the cornea may be related to the immune-privilege of the
eye.1,2 In addition, the presence of anti-angiogenic factors,
such as sFlt, VEGFR3, and thrombospondin-1, have been
associated with avascularity of the cornea.1–3
The wound healing that follows corneal transplantation
involves the growth of blood and lymphatic vessels as part of
the acute inflammatory response. The lymphatics provide a
route for the transport of antigens by antigen-presenting cells
(APC) via the efferent pathway to the regional lymph node.
After antigen presentation, activated T cells return to the
cornea via the blood vessels, a process referred to as the
afferent pathway.4–6 Corneal transplantation in the absence of
vascularization has the lowest rejection rates and graft survival
approaches 90%.7,8 In contrast, vascularized corneas have
much higher rejection rates with survival below 50%.8,9 It is
well known that host C57BL/6 allo-corneal transplantations
have a higher rejection rate than host BALB/c- allo corneal
transplantations.10 This difference in rejection rate can be
explained, at least in part, by differential immunological
responses between BALB/c and host C57BL/6 mouse strains.11
MPS and other innate immune cells (some expressing MHC-
class II antigens) are present in the corneal epithelial layer and
stroma,12–16 especially in the peripheral cornea (limbus).17
Following the induction of inflammation, MPS are activated
and the expression of MHC-class II, as well as co-stimulatory
molecules, such as CD80 (B7.1), CD86 (B7.2), and CD40, is
increased.17,18 We and others have found that activated MPS
can contribute to lymphatic vessels in inflammation-associated
lymphangiogenesis.19–21 Based on these observations, we
postulated that the differences in endogenous MPS might
account for the observed difference in graft rejection rate.
METHODS
Mouse Corneal Transplantation and Corneal
Suture Placement Models
Male BALB/c and C57BL/6 mice (Taconic Farms, Germantown, NY and
Crea Japan, Shizuoka, Japan), CD11b-/- (B6.129S7-Ifngtm1Ts/J mice;
The Jackson Laboratory, Bar Harbor, ME),22 and F4/80-/-23 mice were
used at 8–12 weeks of age. All animal protocols were approved by
Schepens Animal Care and Use Committee, and the Committee for
Animal Research of Kyoto Prefectural University of Medicine in
accordance with the Association for Research in Vision and Ophthal-
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mology (ARVO) Statement for the Use of Animals in Ophthalmic and
Vision Research.
For the corneal transplantation, each animal was anesthetized by an
intraperitoneal (IP) injection of 3 mg ketamine and 0.007 mg xylazine
before the surgical procedure. The central 2-mm portion of the donor
cornea was excised with Vannas scissors and secured in recipient graft
beds with 8 interrupted 11-0 nylon sutures (MANI Inc, Tochigi,
Japan).24 For the suture placement, three 11-0 nylon sutures were
placed intrastromally using stromal incursions that encompassed more
than 120 degrees of the corneal circumference. To obtain a
standardized angiogenic response, the outer edge of the suture was
placed halfway between the limbus and the line outlined by the 2-mm
trephine; the inner edge was equidistant from the 2-mm trephine.
Sutures were left in place for seven days.
Whole-Mount Determination of Blood and
Lymphatic Vessels
Mice were euthanized by CO2 inhalation, and the corneas were excised,
rinsed three times in PBS, and fixed in acetone for 1 hour. The corneas
were rinsed once in PBS, blocked with 2% BSA containing PBS, and
incubated with rabbit anti-mouse LYVE-1 antibody (1:200; a lymphatic
endothelium-specific hyaluronic acid receptor; RELIATECH, Wolfenbu¨t-
tel, Germany).25,26 The corneas were washed, blocked, and stained
with Cy3-conjugated secondary antibody (1:100; Jackson Immuno-
Research Laboratories, Westgrove, PA). For visualization, stained whole-
mount corneas were viewed under a Zeiss Axiophot microscope, and a
Leica TSC-SP2 inverted and an upright confocal laser-scanning
microscope. Digital images of the flat mounts were taken using a spot
image analysis system, and the area covered by lymphatic vessels
positive for LYVE-125,26 was measured using NIH Image software. The
total corneal area was outlined using the innermost vessel of the limbal
arcade as the border; the area of lymphatic vessels within the cornea
was calculated and normalized to the total corneal area. Results are
expressed as a percentage of the cornea covered by vessels.
Whole-Mount Determination of CD11b Positive
Cells
For the whole mount corneal staining, corneas were removed and
fixed with acetone for 1 hour, then rinsed in PBS, blocked with 2% BSA
containing PBS, incubated with FITC, PE-conjugated CD11b (BD-
Pharmingen, San Diego, CA) or anti-mouse F4/80 (1:100). Rat (DA)
IgG2b, j (1:100, BD Pharmingen) was used as an isotype control.
Corneas then were washed, blocked, and stained with FITC or PE
conjugated CD40 and MHC-class II (Iad; BALB/c, Iab; C57BL/6; BD-
Pharmingen). Double-stained whole mount corneas were visualized
and photographed as described above. The same laser status was used
when taking pictures in BALB/c and C57BL/6 mouse cornea. CD11bþ
cells were counted 300 l from the corneal margin for the entire
circumference of the cornea (limbal area).
Systemic and Local Depletion of MPS Using
Clodronate Liposomes
Systemic and local depletion of monocytes/MPS was accomplished as
described previously.27 Cl2MDP (clodronate; a gift of Roche Diagnos-
tics GmbH, Mannheim, Germany) was injected via tail vein (200 lL)
and into subconjunctival space (40 lL) of C57BL/6 mice three times in
a week (days 0, 3, and 5). Control mice received liposomes containing
PBS at the same time points.
Immunofluorescence Staining for F4/80, LYVE-1,
and 40,6-Diamidino-2-Phenylindole (DAPI)
After fixation with 4% paraformaldehyde (PFA) at 48C for 24 hours, the
corneas were washed three times with PBS, placed into Tissue-Tek, and
frozen -808C for 24 hours. Sections (4 lm) were fixed with 99% cold
acetone for two minutes, washed three times with PBS, then blocked
with 0.3% Triton-x100 and 2% BSA containing PBS for 30 minutes. The
corneas were incubated with primary antisera rabbit anti-F4/80
(1:1000; Serotec, Oxford, UK), MHC class II (1:1000; eBioscience) or
LYVE-1 overnight at 48C, then washed, blocked and the secondary Cy3-
conjugated donkey anti-rabbit (1:2500; Jackson ImmunoResearch,
Westgrove, PA) or FITC-conjugated goat anti-rat (1:2500, Jackson
ImmunoResearch) was added for 30 minutes, followed by washing.
Then, the corneas were washed with PBS, and mounting with
VECTASHIELD with DAPI (Vector, Burlingame, CA).
RESULTS
Presence of Innate Immune Cells in the Inflamed
Cornea
We demonstrated previously the development of lymphatic
vessels in the cornea after transplantation.19 At day three after
transplantation, lymphatic vessels began to grow into corneal
stroma. Corneal lymphangiogenesis has been shown to be
associated with CD11bþ MPS.19 Therefore, we investigated the
presence of MPS in cornea at day three after transplantation.
We used the corneal transplantation model of inflammation to
assess macrophage infiltration into corneal stroma. Three days
after BALB/c syngeneic corneal transplantation (Fig. 1a), the
mice were euthanized, and the corneas were dissected from
the limbus, fixed, and stained with anti-CD11b-FITC conjugat-
ed antibody. In the na¨ıve, non-transplanted cornea there was a
small number of CD11bþ cells, primarily in the limbal area (Fig.
1b). In contrast, inflamed corneas, such as after transplanta-
tion, contained large numbers of CD11bþ cells (Fig. 1c).
Similarly, sections of inflamed corneas revealed many MHC
class IIþ cells (Fig. 1d). Moreover, some of the F4/80þ cells
expressed LYVE-1 and had aligned with lymphatic vessels (Fig.
1e).
Comparison of CD11bþ in BALB/c and C57BL/6
Mouse Corneas
The presence in the corneal stroma of bone marrow-derived
CD11bþ MPS has been reported previously.28 Quantification
revealed significantly more CD11bþ cells in C57BL/6 mouse
corneas than in BALB/c mouse corneas (P < 0.01: C57BL/6
1439 6 203SE, BALB/c 465 6 74 SE). MHC class IIþ cells were
located at limbal area under non-inflamed condition. As for
CD11bþ cells, the number of MHC class IIþ cells in C57BL/6
mice was higher than in BALB/c mice (Figs. 2a, b). Most of the
CD11bþ cells were in the stromal layer of the limbus. These
cells also expressed CD40 and MHC-class II marker (Fig. 2c).
There was a relatively small number of CD40 expressing cells
in BALB/c mice corneas (data not shown). These results
indicate that C57BL/6 mouse corneas have higher numbers of
endogenous activated (MHC class II and CD40þ) CD11bþ cells
than BALB/c mouse corneas, suggesting a low level of chronic
MPS activation in the limbal areas of C57BL/6 mice.
Comparison of Blood and Lymphatic Vessels in
Naive BALB/C and C57BL/6 Mouse Corneas
It has been reported previously that the lymphangiogenic
response in the cornea is strain-dependent.29 In addition, the
presence of spontaneous lymphatic vessels has been demon-
strated in normal mouse cornea.30 Although the cornea
generally is considered to be devoid of blood and lymphatic
vessels (Figs. 3a, b), the use of appropriate markers (LYVE-1)
revealed lymphatic vessels (Figs. 3c, e) in the corneal stroma of
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FIGURE 1. Macrophage and MHC class IIþ cell density in the cornea. (a) Microscopic image, and (b, c) flat mounts of corneas stained for the
presence of CD11b (þ) cells. (b) Normal BALB/c corneal limbus and (c) host BALB/c corneal limbus on day 3 after corneal transplantation. Scale bar
is 80 lm. (d) Section of limbus at day 3 after corneal transplantation. Green label (FITC) indicated MHC class II staining, blue label indicates DAPI
staining. Scale bar is 150 lm. (e) Corneal lymphatic vessels at the limbal cornea stained with LYVE-1 (red), F4/80 (green), and DAPI (blue). Scale bar
is 150 lm.
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FIGURE 2. Comparison of CD11b (þ) cell density in C57BL/6 and BALB/c mouse corneas. (a) Whole mount staining of the corneal limbus of normal
C57BL/6 and BALB/c mouse, higher magnification of corneal limbus in normal C57BL/6 and BALB/c mouse. Sections of limbus of normal C57BL/6
and BALB/c mouse. Green label (FITC) indicates MHC class II staining, blue label indicates DAPI staining. (b) Comparison of CD11bþ cell density
between normal C57BL/6 and BALB/c mice (*P < 0.05). (c) Corneal limbus of C57BL/6; MHC-class II (green), CD11b, overlay of (MHC-class II), and
(CD11b), CD40 (green), CD11b (red), overlay of (CD40), and (CD11b). Scale bars are: (a) top 2 figures, 80 lm; (a) lower 2 figures, 20 lm; sections,
150 lm; (c) 40 lm.
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FIGURE 3. Comparison of lymphatic vessel area in corneal limbus between C57BL/6 and BALB/c mice. (a) Normal C57BL/6 mouse. (b) Normal
BALB/c cornea. (c, e) LYVE-1 labeling of lymphatic vessels (red) in C57BL/6 cornea. (d, f) LYVE-1 labeling of lymphatic vessels in BALB/c cornea. (g)
Comparison of lymphatic vessel area in corneal limbus between C57BL/6 and BALB/c mice (P¼ 0.03, n¼ 5). Scale bars are (c, d) 1 mm and (e, f)
100 lm.
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6–8-week-old na¨ıve C57BL/6 mice. In contrast, BALB/c mice
(Figs. 3d, f), which are ‘‘low responders’’ for lymphatic vessel
formation, had significantly fewer lymphatic vessels in cornea
(Fig. 3g, *P ¼ 0.03).
The Effect of MPS Depletion on
Lymphangiogenesis in C57BL/6 Mouse
We showed previously that clodronate depletion of MPS leads
to reduced lymphangiogenesis in the inflamed cornea.19
However, to our knowledge the effect of MPS depletion on
the non-inflamed cornea has not been investigated. Above, we
described the presence of activated MPS expressing CD40 or
MHC-class II in C57BL/6 mouse cornea. We, therefore, sought
to determine whether clodronate deletion of MPS in C57BL/6
corneal stroma would influence the presence of the endoge-
nous lymphatic vessels. Systemic and local clodronate treat-
ment reduced the number of endogenous lymphatic vessel
structures in C57BL/6 mice. Some of the lymphatic vessels
were seen to be separate from limbal lymphatic vessels (Figs.
4a, b; P < 0.05). Moreover, clodronate treatment also led to
fewer CD11bþ cells in lymphatic vessels (some of the CD11bþ
cells expressed both CD11b and LYVE-1) in C57BL/6 mouse
cornea, compared to the untreated corneas (Fig. 4c). These
results suggested that activated endogenous MPS contributed
to the lymphatic vessels seen in C57BL/6 mouse corneas.
Spontaneous Lymphatic Vessel and
Lymphangiogenesis in CD11b-/- and F4/80-/-
Mice
CD11b-/- mice have been reported to exhibit impaired corneal
wound healing under inflammatory conditions.31 However, the
possible role of endogenous corneal lymphatic vessels and
lymphangiogenesis has not been investigated to our knowledge.
Examination of corneas from CD11b-/- and F4/80-/- mice
revealed that the area of endogenous lymphatic vessels was
smaller in CD11b-/- and F4/80-/- mice than in control C57BL/6
mice (Fig. 5a). Using the corneal suture model of inflammation to
assess lymphangiogenesis in CD11b-/-, F4/80-/-, and wild
C57BL/6 mice, we found that the extent of lymphangiogenesis in
CD11b-/- and F4/80-/- mice corneas was less than in wild type
mice (Fig. 5b). These results indicated that F4/80þor CD11bþcells
are important for maintenance of the endogenous lymphatic
vessels and for the process of lymphangiogenesis in the cornea.
DISCUSSION
The cornea is one of the few tissues devoid of blood and
lymphatic vessels. However, our results indicated the presence
of lymphatic vessels in the corneal stroma, particularly in the
limbal area. The endogenous lymphatic vessels were especially
prominent in C57BL/6 mice, but were not detected in corneas
of BALB/c, nor were they seen in corneas of F4/80-/- or
CD11b-/- mice, which have low functional MPS. We
demonstrated previously that the formation of lymphatic
vessels in the cornea correlates well with the number of
activated CD11bþ MPS.19 Furthermore, we have shown that
under inflammatory conditions CD11bþMPS secrete the VEGF-
A and VEGF–C.32 Elimination of these cells by treatment with
clodronate liposomes led to the suppression of inflammation-
induced corneal hem- and lymphangiogenesis to levels less
than control mice.32
Host C57BL/6 mice are known to have a higher rejection
rate after allogeneic corneal transplantation than host BALB/c
mice (50% for C57BL/6 to BALB/c, and 80% for BALB/c to
C57BL/6).11 However, the reason for this difference is not well
understood. One possible explanation is the presence of some,
as yet unidentified, class IIþ cells in the cornea whose number
or immunogenicity differ between these two strains of mice.
Alternatively, the two species might have the same number of
these cells, but the frequency of their migration from the eye to
the lymph node could be different.11 Our data support the
former explanation and demonstrated that C57BL/6 mice have
a higher risk of corneal transplantation rejection because they
contain relatively large numbers of activated CD11bþ cell and
lymphatic vessels compared to BALB/c mice. The larger
number of CD11bþ or MHC class IIþ cells in C57BL/6 mouse
cornea would result in a more rapid and effective detection of
alloantigens than in BALB/c mice.
The involvement of these cells in the rejection reaction is
supported by the fact that MPS depletion via clodronate
liposomes led to a decrease in rejection33 and a suppression of
inflammation-induced lymphangiogenesis.32 Mice depleted of
MPS by clodronate treatment exhibit no alloantigen tolerance
and delayed type hypersensitivity is not suppressed.33 In na¨ıve
(non-inflamed) corneas, intravenous/subconjunctival clodro-
nate liposome injection led to a reduced number of lymphatic
vessels and CD11bþ cells in the C57BL/6 corneal stroma,
suggesting that CD11bþ cell may contribute to the mainte-
nance of lymphatic vessels in these mice.
The role of MPS as a source of cytokines and growth factors,
and as a phagocyte during wound healing, has been well
documented.34 We showed previously that MPS have a key role
in the induction of lymphatic vessels under pathological
conditions in cornea and skin. Some of the MPS that express
lymphatic-specific markers, such as LYVE-1, podoplanin, and
prox-1 contributed to the formation of lymphatic vessels.19,35
In addition, we observed that MPS formed lymphatic vessel-like
tubes in vitro in a density-dependent manner.19 Accordingly,
the lower number of MPS appeared to contribute to the
reduced formation of lymphatic structures in the granulation
tissue of wounds under diabetic conditions.35
The precise role of CD11bþ cells during inflammation is not
well understood. MPS express F4/80 and CD11b. F4/80 is a
prototypic MPS membrane glycoprotein that is highly restrict-
ed to mature resident MPS subpopulations.36 F4/80-/- mice do
not display any apparent abnormality, indicating that F4/80 is
dispensable for the development of mouse tissue MPS.
However, a functional requirement for F4/80 in the production
of TNF-alpha, IL-12 and IFN-gamma after exposure of the
mouse spleen cells to Listeria has been demonstrated.37 Thus,
we speculate that F4/80 may function under pathological
conditions. Also, CD11b is the alpha subunit of the predom-
inant beta2 integrin expressed on monocyte/MPS. CD11b
mediates many functions of myeloid cell, including adhesion,
migration, chemotaxis, and phagocytosis.38 Neutralization of
CD11b using antibodies reduced the leukocyte recruitment
under inflammatory conditions.39 Consistent with this con-
cept, the delay of corneal wound healing in CD11b-/- mouse
might be mediated by dysfunction or reduced recruitment of
monocyte/MPS.31 We have shown that MPS infiltration
(accumulation) into an inflamed site is important for the
induction of lymphangiogenesis.35 The reduced accumulation
of MPS in CD11b-/- and F4/80-/- mice, resulting in fewer
lymphatic vessels than wild type, is consistent with this
observation, Our data indicate that endogenous lymphatic
vessels in the corneas are maintained by activated MPS and,
thus, we speculate that the number of MPS and lymphatic
vessels in C57BL/6 mouse corneal limbus might contribute to
the observed differences in graft rejection between C45BL/6
mice and BALB/c mice. In addition, it is likely that polymor-
phisms, epigenetic changes, and/or other systemic processes
also may influence graft rejection in humans, and any of these
may provide targets for future therapeutic modulation.
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FIGURE 4. The effect of macrophage depletion on lymphangiogenesis in C57BL/6 mouse cornea. (a) Immunofluorescence of C57BL/6 mouse
corneal flat mounts following clodronate liposome treatment and PBS liposome treatment. (b) Comparison of lymphatic vessel area in corneal
limbus following clodronate and PBS liposome treatment (*P < 0.05). (c) LYVE-1 (red) and CD11b (green) immunofluorescent double labeling of
corneas following clodronate or PBS liposome treatment. Scale bars are (a) 100 lm and (c) 40 lm.
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